Scion Asset Management

Scion Asset Management

13F Holdings and Portfolio Analysis

Michael Burry 2025 Q3 13F holdings, quarterly changes, portfolio value trend and position weight distribution.

Scion Asset Management Overview

Scion Asset Management held 8 stocks in 2025 Q3, with total market value around $1.38B.

Scion Asset Management's top five holdings in 2025 Q3: PALANTIR TECHNOLOGIES INC CL A(PLTR) 66.04%, NVIDIA CORPORATION COM(NVDA) 13.51%, Pfizer Inc.(PFE) 11.07%, HALLIBURTON CO(HAL) 4.45%, MOLINA HEALTHCARE INC COM(MOH) 1.73%.

Portfolio Value
$1.38B
Current Holdings
8 stocks
New / Increased
7 / 0
Reduced / Exited
1 / 10

Current Holdings

1PALANTIR TECHNOLOGIES INC CL APLTR0.9166.04%5.00 $182.42$156.54 -14.19%$182.42+5.000.25-$0.13B-14.19%New
2NVIDIA CORPORATION COMNVDA0.1913.51%1.00 $186.58$219.63 +17.71%$186.58+1.000.25+$0.03B+17.71%New
3Pfizer Inc.PFE0.1511.07%6.00 $25.48$24.52 -3.77%$25.48+6.000.25-$0.01B-3.77%New
4HALLIBURTON COHAL0.064.45%2.50 $24.60- $24.60+2.500.25$0.00B0.00%New
5MOLINA HEALTHCARE INC COMMOH0.021.73%0.13 $191.36- $191.36+0.130.25$0.00B0.00%New
6lululemon athletica inc.LULU0.021.29%0.10 -77.78%$177.93$167.41 -5.91%$237.58-0.350.50-$0.01B-29.54%Reduced
7SLM CORP COMSLM0.010.96%0.48 $27.68- $27.68+0.480.25$0.00B0.00%New
8BRUKER CORPBRKR0.010.95%0.05 $271.80- $271.80+0.050.25$0.00B0.00%New
Showing 1-8 of 8

"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.

Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.

Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.

Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.

Exited Holdings

Stocks no longer disclosed in the current 13F portfolio for 2025 Q3.

1UNITEDHEALTH GROUP INC COMUNH0.370.25$311.97$345.30+$0.01B+10.68%
2Regeneron Pharmaceuticals, Inc.REGN0.210.25$525.00$525.00$0.00B0.00%
3Meta Platforms, Inc.META0.100.25$738.09$734.38-$0.00B-0.50%
4LAUDER ESTEE COS INC CL AEL0.650.75$77.63$88.12+$0.01B+13.52%
5JD.com, Inc.JD1.002.00$34.82$34.98+$0.00B+0.46%
6Alibaba Group Holding LimitedBABA0.252.00$105.65$178.73+$0.02B+69.17%
7ASML Holding N.V.ASML0.030.25$801.39$968.07+$0.00B+20.80%
8V F CORP COMVFC1.500.25$11.75$14.43+$0.00B+22.81%
9BRUKER CORPBRKR0.250.25$41.20$41.20$0.00B0.00%
10MercadoLibre, Inc.MELI0.000.25$2613.63$2336.94-$0.00B-10.59%
Showing 1-10 of 10

Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.

"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.

Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.

Exit return shows estimated dollar return on top and percentage return below.

Portfolio Visuals

Track portfolio value, position weights and Top 10 history.

Market Value Trend ($B)

32 periods

Position Weight

TOP10

Holding Changes ($B)

All-period Top 10

Top 10 Holdings Replay

Animated view